Drugged driving [DD] is a public health concern, particularly among emerging adults who have the highest rates of drug use. Understanding involvement with DD could inform prevention efforts for this population. We evaluated the prevalence of, motives for, and correlates of past-year DD among emerging adults from an urban, under-resourced community.
Current levels and dangers of opioid use in the U.S. warrant the investigation of harm-reducing treatment alternatives. The clinically and statistically significant evidence of an association between medical cannabis programme enrollment and opioid prescription cessation and reductions and improved quality of life warrants further investigations on cannabis as a potential alternative to prescription opioids for treating chronic pain.
Live Streaming of the whole event The live streaming of the 4th Annual Golden Tarp Awards can be found here. Streaming begins at 11am (7pm in the UK) THE AWARDS There are FOUR main awards being presented to the contestants of the Annual Golden Tarp Awards! We at The Ganjier believe that we have some of the…
Back to the Future: Ortega Indica – The Perfect Soporific Ortega Indica is the first medical strain officially classified as such by Dutch Passion. Its pedigree dates back to original stock from breeder Neville’s legendary Seed Bank of the eighties, consisting of the original Ortega Indica and Northern Lights #1. Henk from Dutch passion reports…
Early XXX has been developed to grow outdoors in northern Europe and has a great number of desirable traits It is not always easy to grow a plant outside, especially when you live in a cold country. In northern Europe, for example, the summers are not particularly hot and the autumn, with its loads of…
The endocannabinoid system (ECS) primarily consists of cannabinoid receptors (CBRs), endogenous ligands, and enzymes for endocannabinoid biosynthesis and inactivation. Given the varying and sometimes limited efficacy of current medical therapies for diseases of the esophagus, further understanding and investigation into the interplay of the ECS on esophageal health and disease may present new therapeutic modalities that may help advance current treatment options.
Cannabidiol (CBD) and ∆9-tetrahydrocannabinol (THC) have well documented immunomodulatory effects in vitro, but not following oral administration in humans. Immune cells from MS patients were more susceptible to the immunosuppressive effects of cannabinoids than those from healthy volunteers or cancer patients. Administering cannabinoids with a high-fat meal or in lipid-based formulations has the potential to be a therapeutic approach to improve the treatment of MS, or indeed other autoimmune disorders.
There is considerable public and political interest in the use of cannabis products for medical purposes. The task force of the European Pain Federation (EFIC) conducted a survey with its national chapters representatives on the status of approval of all types of cannabis-based medicines, the covering of costs and the availability of a position paper of a national medical association on the use of medical cannabis for chronic pain and for symptom control in palliative/supportive care.
Multiple sclerosis is the most common inflammatory demyelinating disease of the central nervous system, caused by an autoimmune response against myelin that eventually leads to progressive neurodegeneration and disability. Although the knowledge on its underlying neurobiological mechanisms has considerably improved, there is a still unmet need for new treatment options, especially for the progressive forms of the disease. Both preclinical and clinical data suggest that cannabinoids, derived from the Cannabis sativa plant, may be used to control symptoms such as spasticity and chronic pain
The last tarps have been pulled in the Emerald Triangle and the harvest has been cured, but a question lingers. What strains and names are the cream of this year’s light dep cannabis crop? The 4th annual Golden Tarp Award aims to find out on Saturday and you can watch it live online. This…